Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death

被引:10
作者
de Lima, TM
Lima, MMR
Almeida, DCG
Mendonça, JR
Curi, R
机构
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508900 Sao Paulo, Brazil
[2] Univ Fortaleza, Dept Nutr, Fortaleza, Ceara, Brazil
基金
巴西圣保罗研究基金会;
关键词
apoptosis; Bcl-x(L); caspase-3; lymphocytes; tumor cachexia;
D O I
10.1007/s00262-004-0570-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Death induction by Walker 256 tumor cachexia in non-tumor-infiltrating lymphocytes was investigated. Lymphocytes from cachectic tumor-bearing rats presented a higher proportion of cells with ruptured membranes, indicating necrotic cell death. The cachexia induced by Walker 256 tumor also increased by 3.6-fold the percentage of cells with fragmented DNA, suggestive of apoptotic cell death. The mitochondria involvement was examined by analysis of mitochondria transmembrane potential using rhodamine 123. Lymphocytes from cachectic tumor-bearing rats presented a more pronounced depolarization of mitochondrial transmembrane potential in comparison with cells from the control group. The expression of important proapoptotic (Bcl-x(s), Bax, p53, caspase-3) and antiapoptotic genes (Bcl-2 and Bcl-x(L)) was also altered by tumor cachexia. These results suggest that the immunosuppression induced by Walker 256 tumor cachexia is at least in part a result of lymphocyte death. Evidence was found for the involvement of mitochondria and important proapoptotic genes in the process of lymphocyte death by Walker 256 tumor cachexia.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 36 条
  • [1] Cancer cachexia:: the molecular mechanisms
    Argilés, JM
    Moore-Carrasco, R
    Fuster, G
    Busquets, S
    López-Soriano, FJ
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (04) : 405 - 409
  • [2] The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
    Borner, C
    [J]. MOLECULAR IMMUNOLOGY, 2003, 39 (11) : 615 - 647
  • [3] T cell-tumor cell: a fatal interaction?
    Chappell, DB
    Restifo, NP
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (02) : 65 - 71
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] Antiproliferative prostaglandins and the MRP/GS-X pump role in cancer immunosuppression and insight into new strategies in cancer gene therapy
    de Bittencourt, PIH
    Curi, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 2001, 62 (07) : 811 - 819
  • [6] The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
    Dumont, P
    Leu, JIJ
    Della Pietra, AC
    George, DL
    Murphy, M
    [J]. NATURE GENETICS, 2003, 33 (03) : 357 - 365
  • [7] Tumor-induced immune dysfunction: The macrophage connection
    Elgert, KD
    Alleva, DG
    Mullins, DW
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) : 275 - 290
  • [8] INSULIN-SECRETION IN WALKER-256 TUMOR CACHEXIA
    FERNANDES, LC
    MACHADO, UF
    NOGUEIRA, CR
    CARPINELLI, AR
    CURI, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (06): : E1033 - E1036
  • [9] Immunologic mechanisms of antitumor activity
    Foss, FM
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 5 - 11
  • [10] Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events
    Gastman, BR
    Johnson, DE
    Whiteside, TL
    Rabinowich, H
    [J]. BLOOD, 2000, 95 (06) : 2015 - 2023